StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
BPC.CN$0.50-1.96%
Fair $0.50+0.0%

BPC.CN

The Precision Peptide Company Inc.

Consumer Defensive / Packaged FoodsCanadian Sec

$0.50

-0.01 (-1.96%)

Fairly Valued+0.0%Fair Value $0.50Fund rank 24/100 · Data gapFallback financials|
SA 23/D
F-Score: 2/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 17%

FCF escenarios

weak_data · normalized FCF $-980681.00 · quality 39.7/100

Data gap 24/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 19/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

23/100

D

Piotroski

2/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -4.9%, below the 5% threshold
Thesis & Journal · BPC.CNLocal privado en este navegador · The Precision Peptide Company Inc.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$22M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-486.9%

↓

Gross Margin

44.1%

↑

Debt/Equity

N/A

•
52-Week Range$1
$0$1

TradingView lightweight chart

BPC.CN price, volumen y niveles de valoración

Último $0.500Periodo -35.9%
Fair value: $0.500

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-55.9%

FCF CAGR

—

FCF margin

-4694.1%

FCF / Net income

0.52x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $49720.0 · net income $-4.5M · FCF $-2.3M

2022-FY → 2025-FY

Gross margin

44.1%+37.1% pts

Operating margin

-4529.9%-4375.2% pts

Net margin

-9104.3%-8910.2% pts

FCF margin

-4694.1%-4569.2% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$49720.00$49720.00$12202.00$285590.00$580987.00
Net Income$-4.5M$-4.5M$-1.0M$-1.7M$-1.1M
EBITDA$-2.2M$-2.2M$-917205.00$-1.6M$-855301.00
EPS-0.21-0.21-0.15-0.29-0.24
Gross Margin44.1%44.1%56.6%-11.5%7.0%
Operating Margin-4529.9%-4529.9%-7545.5%-564.3%-154.8%
Net Margin-9104.3%-9104.3%-8450.2%-581.4%-194.1%
Balance Sheet
Debt/Equity——-0.03——
Current Ratio1.701.70———
Cash Flow
Free Cash Flow$-2.3M$-2.3M$-439413.00$-980681.00$-725801.00
Returns
ROE-486.9%-486.9%187.3%1200.7%-515.6%
Valuation
P/B11.6511.65——16.28
Growth & Yield
Revenue Growth307.5%307.5%-95.7%-50.8%—
EPS Growth-40.0%-40.0%48.3%-20.8%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +42.9%

Total return

+42.9%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.15 → -0.21

Residual

+42.9%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+42.9%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.